share_log

B of A Securities Maintains Neutral on ProKidney, Raises Price Target to $4

Benzinga ·  May 29 17:21

B of A Securities analyst Jason Gerberry maintains ProKidney (NASDAQ:PROK) with a Neutral and raises the price target from $3 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment